Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy

European Radiology

Volumn 25, Issue 8, 2015, Pages 2428-2436

  Yu, Mi Hye ^a   Lee, Jeong Min ^b   Hur, Bo Yun ^c   Kim, Tae You ^b   Jeong, Seung Yong ^b   Yi, Nam Joon ^b   Suh, Kyung Suk ^b   Han, Joon Koo ^b   Choi, Byung Ihn ^b  

^a Konkuk University Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Colorectal cancer; Gadoxetic acid; Liver metastasis; Magnetic resonance imaging; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; FLUOROURACIL; FOLINIC ACID; GADOXETIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; OXALIPLATIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANGIOGRAPHIC INJECTOR; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SIZE; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEATOSIS; VERY ELDERLY; CASE CONTROL STUDY; COLORECTAL TUMOR; EVALUATION STUDY; LIVER NEOPLASMS; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SECONDARY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVER VARIATION; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84937631816     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3615-5     Document Type: Article

References (32)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259
3. Leonard GD, Brenner B, Kemeny NE (2005) Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23:2038–2048
4. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271–1280
5. Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11:1057–1077
6. Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644–657, discussion 657–648
7. Adam R, Pascal G, Castaing D et al (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052–1061, discussion 1061–1054
8. Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684
9. Robinson PJ (2009) The effects of cancer chemotherapy on liver imaging. Eur Radiol 19:1752–1762
10. Pilgrim CH, Thomson BN, Banting S, Phillips WA, Michael M (2012) The developing clinical problem of chemotherapy-induced hepatic injury. ANZ J Surg 82:23–29
11. Carnaghi C, Tronconi MC, Rimassa L et al (2007) Utility of 18 F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Nucl Med Rev Cent East Eur 10:12–15
12. Angliviel B, Benoist S, Penna C et al (2009) Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol 16:1247–1253
13. Spatz J, Holl G, Sciuk J, Anthuber M, Arnholdt HM, Markl B (2011) Neoadjuvant chemotherapy affects staging of colorectal liver metastasis–a comparison of PET, CT and intraoperative ultrasound. Int J Colorectal Dis 26:165–171
14. van Kessel CS, van Leeuwen MS, van den Bosch MA et al (2011) Accuracy of multislice liver CT and MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy. Dig Surg 28:36–43
15. van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19:2805–2813
16. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE (2011) Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol 46:548–555
17. Chen L, Zhang J, Zhang L et al (2012) Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7:e48681
18. Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK (2013) Gd-EOB-DTPA-enhanced MRI for detection of liver metastases from colorectal cancer: a surgeon’s perspective! Int J Hepatol 2013:572307
19. Chung WS, Kim MJ, Chung YE et al (2011) Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J Magn Reson Imaging 34:345–353
20. Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM (2012) Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 85:980–989
21. Kim YK, Lee MW, Lee WJ et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (
22. Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS (2013) Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Eur J Radiol 82:822–828
23. Macera A, Lario C, Petracchini M et al (2013) Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy. Eur Radiol 23:739–747
24. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342–357
25. Chakraborty DP, Winter LH (1990) Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 174:873–881
26. Metz CE (1986) ROC methodology in radiologic imaging. Invest Radiol 21:720–733
27. Shin NY, Kim MJ, Lim JS et al (2012) Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 22:864–871
28. Lubezky N, Metser U, Geva R et al (2007) The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11:472–478
29. Jeong HT, Kim MJ, Park MS et al (2012) Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging 35:635–643
30. Lowenthal D, Zeile M, Lim WY et al (2011) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21:832–840
31. Han NY, Park BJ, Sung DJ et al (2014) Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation. Radiology 271:416–425
32. Tamada T, Ito K, Ueki A et al (2012) Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver. J Magn Reson Imaging 35:852–858